Abstract: Non-classical actions of vitamin D were first suggested over 30 years ago when receptors for the active form of vitamin D, 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), were detected in various tissues and cells that are not associated with the regulation of calcium homeostasis, including activated human inflammatory cells. The question that remained was the biological significance of the presence of vitamin D receptors in the different tissues and cells and, with regard to the immune system, whether or not vitamin D plays a role in the normal immune response and in modifying immune mediated diseases. In this article findings indicating that vitamin D is a key factor regulating both innate and adaptive immunity are reviewed with a focus on the molecular mechanisms involved. In addition, the physiological significance of vitamin D action, as suggested by in vivo studies in mouse models is discussed. Together, the findings indicate the importance of 1,25(OH) 2 D 3 as a regulator of key components of the immune system. An understanding of the mechanisms involved will lead to potential therapeutic applications for the treatment of immune mediated diseases.
Introduction
Although the importance of vitamin D for curing rickets has been known for over 80 years, in the past several years there has been a renewed interest in vitamin D. This is due not only to an increased awareness of the importance of vitamin D for mineralization but also to the realization that vitamin D has many other effects including preventing or, at least partially, protecting against a number of autoimmune diseases (for example, experimental autoimmune encephalomyelitis (EAE; the murine model of multiple sclerosis, MS) and inflammatory bowel disease (IBD). Vitamin D has also been reported to regulate innate immunity by increased production of antimicrobial peptides and subsequent killing of bacteria. In spite of the potential importance of vitamin D over a wide range of immune disorders, the mechanisms involved in vitamin D regulation of immune responses and how vitamin D is involved in linking innate and adaptive immunity have not been clearly defined and are topics of ongoing investigation. 1,25(OH) 2 D 3 , the hormonally active form of vitamin D, is produced by two sequential hydroxylations: by 25-hydroxylase in the liver (it has been suggested that CYP2R1, which is also present in extra-hepatic sites, is the key vitamin D 25-hydroxylase in the liver) and by 25-hydroxyvitamin D 1α hydroxylase (CYP27B1) in the kidney [1] [2] [3] . The actions of 1,25(OH) 2 D 3 are mediated, similar to other hormones, by a nuclear receptor (vitamin D receptor, VDR) which heterodimerizes with the retinoid X receptor and binds to vitamin D response elements (VDREs) in target genes and modulates their transcription [4] [5] [6] . 1,25(OH) 2 D 3 modulates two separate, but interacting, types of immunity: innate and adaptive. Effects on each system, including molecular mechanisms involved, will be reviewed and in vivo studies in mouse models will be discussed.
Nutrients 2015, 7, 8251-8260 converge with the TLR induced interleukin 1 beta (IL-1β) signaling pathway to induce the expression of the antimicrobial peptide defensin beta 4 (DEFB4; formally HBD2) in monocytes [22] . Additional mechanisms by which vitamin D induces innate antimicrobial effector responses include induction of reactive oxygen intermediates and activation of antibacterial autophagy [23, 24] . Although these in vitro findings present convincing evidence of 1,25(OH)2D3-mediated antimicrobial activity, further studies are needed to determine the effect of 1,25(OH)2D3 in vivo on host resistance to bacteria. Since 1,25(OH)2D3 regulation of CAMP is specific to humans and non-human primates [12] , future studies using a transgenic humanized mouse expressing the human CAMP gene (generated by the A. Gombart lab, personal communication) will provide important insight into mechanisms and effects of 1,25(OH)2D3 in vivo in response to infection. 
Vitamin D and the Adaptive Immune Response
Although 1,25(OH)2D3 promotes the innate immune response, it is a suppressor of adaptive immunity [25] [26] [27] . 1,25(OH)2D3 suppresses immune responses mediated by Type 1 T helper (Th1) cells which are capable of producing inflammatory cytokines. Inflammatory cytokines produced by Th1 cells and repressed by 1,25(OH)2D3 include IL-2 and interferon gamma (IFNγ) [28] . A direct effect of 1,25(OH)2D3/VDR on IL-2 and IFNγ transcription has been reported. The suppressive effect of 1,25(OH)2D3 on IL-2 transcription results, at least in part, from the blocking of NFAT/AP-1 complex formation by VDR/retinoid X receptor (RXR) and association of VDR/RXR with the NFAT element in the IL-2 promoter as well as sequestration of Runx1 by 1,25(OH)2D3/VDR [29, 30] (Figure 1 [30, [35] [36] [37] . 1,25(OH) 2 D 3 has been shown to up-regulate Foxp3 at the transcriptional level (a VDRE was identified in the highly conserved non-coding region of the mouse Foxp3 gene) [30] (Figure 1 ). In addition to Th1, Th2, and Treg cells (subsets from the CD4 + T cell lineage), IL-17 producing T cells are a distinct subset termed Th17 cells. IL-17, which has been implicated in the pathogenesis of a number of autoimmune diseases, is inhibited by 1,25(OH) 2 D 3 [30, 38, 39] . The mechanism of the negative effect of 1,25(OH) 2 D 3 on IL-17 involves blocking NFAT and Runx1 binding to the IL-17 promoter and induction of Foxp3 (which binds to and inhibits NFAT and Runx1) [30] . 1,25(OH) 2 D 3 may also result in suppression of IL-17 through inhibition of the transcription factor RORγt which is required for the differentiation of Th17 cells [40] (Figure 1 ). 1,25(OH) 2 D 3 also inhibits differentiation of dendritic cells resulting in a suppression of the pro-inflammatory cytokine IL-12 and an increase in IL-10, an anti-inflammatory cytokine produced by Th2 cells [41] [42] [43] . In addition to blocking dendritic cell differentiation, IL-12 production is also repressed by 1,25(OH) 2 D 3 at the level of transcription (VDR/RXR has been reported to bind to the NF-κB site in the IL-12p20 promoter, thus preventing activation by NF-κB) [44] . It is increasingly recognized that actions of 1,25(OH) 2 D 3 , similar to other steroids, are complex, involving regulation of gene activity at a range of locations, often many kilobases from the gene's start site. Although the mechanisms involved in VDR gene regulation in immune cells are beginning to be addressed, further genome-wide studies are needed to define the multiple control regions and global networks involved in 1,25(OH) 2 D 3 regulation of immune function.
Vitamin D and Autoimmune Diseases (MS and IBD)
The geographic incidence of MS and IBD indicates a negative correlation between increased sun exposure and MS and IBD prevalence [45] [46] [47] . MS and IBD are almost unknown in equatorial regions. Since the synthesis of vitamin D in the skin from 7 dehydrocholesterol by ultraviolet (UV) irradiation is the most important source of vitamin D (few foods contain vitamin D) and vitamin D deficiency has been associated with increased incidence of MS and IBD [48, 49] , a beneficial effect of vitamin D for prevention and treatment of these autoimmune diseases has been suggested. It should be noted that the negative correlation between sun exposure and MS may be due, in part, to vitamin D but may also be due to the previously reported effects of UV irradiation on the immune system independent of vitamin production [50, 51] . In the study of Becklund et al. [51] [30, [55] [56] [57] . Although 1,25(OH) 2 D 3 inhibits EAE and VDR is necessary for this inhibition, studies in VDR knockout (KO) mice have shown that EAE is less severe in VDR null mice and the onset is delayed, suggesting that VDR is needed for the development of immune responses involved in the induction of EAE [58, 59] . With regard to IBD, VDR KO mice develop more severe symptoms of IBD which are accompanied by increased numbers of IL-17 and IFNγ secreting cells [60] . Treatment with 1,25(OH) 2 D 3 of experimentally-induced colitis in WT mice reduces inflammation [57, 60] . Although suppression of Th1 and Th17 cells and induction of Th2 and T reg cells have been reported to be responsible for the beneficial effect of 1,25(OH) 2 D 3 in IBD, induction of DSS (dextran sulfate sodium) colitis in T cell deficient mice has been shown, suggesting that other pathways are also involved in the protective effect of 1,25(OH) 2 D 3 in experimental IBD [61] . Recently mice expressing VDR exclusively in the distal ileum and in the cecum and colon of VDR KO mice (KO/transgenic (TG) mice) were generated and used as a model to determine the role of intestinal epithelial cells in the susceptibility of VDR KO mice to IBD (Figure 2 ; [62, 63] ). The full length human (h)VDR cDNA under the control of the 9.5 kb Cdx2 promoter (from E. Fearon; [64] ) which directs transgene expression specifically in the ileum, cecum and colon was used to obtain founders that resulted in high (TG1 and 2) or low (TG3) hVDR expression. TG mice were mated to VDR KO mice to obtain mice with VDR expressed exclusively in the distal intestine (Figure 2A ). In the KO/TG1 and 2 mice, which have a similar phenotype, transgenic expression of VDR restricted to the distal intestine rescued the skeletal abnormalities observed in the VDR KO mice and serum parathyroid hormone (PTH) and calcium levels were normalized [62, 65] . In the KO/TG3 mice (low VDR expression; less than 50% of the levels of VDR protein observed in KO/TG1 and 2 mice, Figure 2A , Western blot) serum calcium levels were similar to VDR KO mice and PTH levels remained elevated but were significantly less than the levels observed in the VDR KO mice [62] . The skeletal abnormalities in VDR KO mice were not rescued in KO/TG3 mice but were not as severe as in the VDR KO mice [62] . KO/TG2 and KO/TG3 mice were used for DSS colitis studies ( Figure 2B-F) . KO/TG2 mice, which express VDR only in the epithelial cells of the distal intestine at levels equivalent to wild type (WT) mice, were more resistant to DSS colitis when compared to VDR KO mice (displaying a milder form of colitis, similar to WT mice, including marked reductions in rectal bleeding and colonic blood score; Figure 2B -E: KO/TG2). Also, at seven days post DSS treatment weight loss was observed in VDR KO mice (88%˘3% of the original weight) but not in WT or KO/TG2 mice. In the transgenic line KO/TG3, with low VDR expression, DSS treatment resulted in more severe symptoms ( Figure 2C Since increased calcium intake has previously been reported to ameliorate the symptoms of IBD in transgenic rats by strengthening the mucosa barrier [66] , it is possible that an increase in calcium, mediated by 1,25(OH) 2 Additional mechanisms suggested to be involved in the protective effect of 1,25(OH) 2 D 3 in IBD include regulation of the composition of the gastrointestinal microflora and a reduction in intestinal epithelial cell apoptosis [67, 68] . Administration of antimicrobial peptides has been proposed as a therapeutic strategy against IBD [69] . Thus, it is possible that effects on antimicrobial peptides are also involved in maintenance of intestinal homeostasis by 1,25(OH) 2 D 3 and are not restricted to 1,25(OH) 2 D 3 effects related to infectious diseases. 
Conclusions

